AU8091091A - Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule - Google Patents

Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule

Info

Publication number
AU8091091A
AU8091091A AU80910/91A AU8091091A AU8091091A AU 8091091 A AU8091091 A AU 8091091A AU 80910/91 A AU80910/91 A AU 80910/91A AU 8091091 A AU8091091 A AU 8091091A AU 8091091 A AU8091091 A AU 8091091A
Authority
AU
Australia
Prior art keywords
albumin
peptides
proteins
drug delivery
delivery systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU80910/91A
Inventor
Dee A Casteel
John M. Dagle
Scott Fowler
Gerald D Hurst
Joseph A. Walder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Publication of AU8091091A publication Critical patent/AU8091091A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU80910/91A 1990-07-26 1991-06-03 Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule Abandoned AU8091091A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55878990A 1990-07-26 1990-07-26
US558789 1990-07-26

Publications (1)

Publication Number Publication Date
AU8091091A true AU8091091A (en) 1992-02-18

Family

ID=24230995

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80910/91A Abandoned AU8091091A (en) 1990-07-26 1991-06-03 Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule

Country Status (2)

Country Link
AU (1) AU8091091A (en)
WO (1) WO1992001476A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869930B1 (en) 1993-09-17 2005-03-22 Novo Nordisk A/S Acylated insulin
CN1056618C (en) * 1993-09-17 2000-09-20 诺沃挪第克公司 Acylated insulin
US5693609A (en) * 1994-11-17 1997-12-02 Eli Lilly And Company Acylated insulin analogs
US5646242A (en) * 1994-11-17 1997-07-08 Eli Lilly And Company Selective acylation of epsilon-amino groups
US6251856B1 (en) 1995-03-17 2001-06-26 Novo Nordisk A/S Insulin derivatives
US5631347A (en) * 1995-06-07 1997-05-20 Eli Lilly And Company Reducing gelation of a fatty acid-acylated protein
US5700904A (en) * 1995-06-07 1997-12-23 Eli Lilly And Company Preparation of an acylated protein powder
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
US7601691B2 (en) 1999-05-17 2009-10-13 Conjuchem Biotechnologies Inc. Anti-obesity agents
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
WO2006005667A2 (en) 2004-07-08 2006-01-19 Novo Nordisk A/S Polypeptide protracting tags comprising a tetrazole moiety
ES2542146T3 (en) 2006-07-31 2015-07-31 Novo Nordisk A/S PEGylated extended insulin.
CN101541830A (en) 2006-09-22 2009-09-23 诺沃-诺迪斯克有限公司 Protease resistant insulin analogues
EP2114437A2 (en) 2006-10-16 2009-11-11 ConjuChem Biotechnologies Inc. Modified corticotropin releasing factor peptides and uses thereof
US9395352B2 (en) 2007-04-06 2016-07-19 Arizona Board Of Regents On Behalf Of Arizona State University Devices and methods for target molecule characterization
EP2152245B1 (en) 2007-04-30 2015-12-02 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
US9260502B2 (en) 2008-03-14 2016-02-16 Novo Nordisk A/S Protease-stabilized insulin analogues
RU2571857C2 (en) 2008-03-18 2015-12-20 Ново Нордиск А/С Acylated insulin analogues stabilised with respect to proteases
WO2010042514A1 (en) 2008-10-06 2010-04-15 Arizona Board Of Regents Nanopore and carbon nanotube based dna sequencer and a serial recognition elements
MY163552A (en) 2010-12-14 2017-09-29 Sasol Tech (Proprietary) Limited Cleaning of process equipment
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
US9274430B2 (en) 2012-10-10 2016-03-01 Arizona Board Of Regents On Behalf Of Arizona State University Systems and devices for molecule sensing and method of manufacturing thereof
US9952198B2 (en) 2013-03-05 2018-04-24 Arizona Board Of Regents On Behalf Of Arizona State University Translocation of a polymer through a nanopore
HUE036702T2 (en) 2013-10-07 2018-07-30 Novo Nordisk As Novel derivative of an insulin analogue
WO2015131073A1 (en) 2014-02-27 2015-09-03 Arizona Board Of Regents Acting For And On Behalf Of Arizona State University Triazole-based reader molecules and methods for synthesizing and use thereof
TWI700091B (en) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 Insulin containing pharmaceutical compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0037388B1 (en) * 1980-03-31 1984-12-12 Institut International De Pathologie Cellulaire Et Moleculaire Pharmaceutical forms, their preparation and compositions containing the same
US5051406A (en) * 1987-03-04 1991-09-24 Nippon Hypox Laboratories Incorporated Pharmaceutical composition using albumin as a carrier and process for producing the same
GB8820378D0 (en) * 1988-08-26 1988-09-28 Offord R E Chemical compounds

Also Published As

Publication number Publication date
WO1992001476A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
AU8091091A (en) Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
IL105529A0 (en) Collagen-containing sponges as drug delivery for proteins
AU664807B2 (en) Drug delivery system
AU4989993A (en) Drug delivery system
EP0758843A4 (en) Modified amino acids for drug delivery
AU4406793A (en) Water-soluble polymeric carriers for drug delivery
AU7170591A (en) Particulate delivery system
IL110024A0 (en) Protein drugs delivery system
AU8263987A (en) Pharmaceutical Delivery Systems
AU624998B2 (en) Pulsatile once-a-day delivery systems for minocycline
AU6295394A (en) Peptide linkers for improved oligonucleotide delivery
AU6820687A (en) Drug delivery system
AU5606394A (en) Automated drug infusion system
AU8935591A (en) Drug delivery system and method
AU8305491A (en) Novel immunosuppressant peptides
AU7216994A (en) Polyvalent peptide pharmaceutical applications
AU4032389A (en) Light delivery system
AU7840994A (en) Active substance delivery system
AU8205591A (en) A pharmaceutical composition comprising a cell adhesion molecule
AU660290B2 (en) Multiple drug delivery system
AU7428691A (en) Long-acting liposome peptide pharmaceutical products and processes for the preparation thereof
AU8072691A (en) Pharmaceutical preparations
AU4635593A (en) Vesicle membrane transport proteins
AU7359487A (en) Receptor-targeted drug delivery systems
GB2245831B (en) Drug delivery system for administering growth factors